{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:12:45Z","timestamp":1790622765897,"version":"4.1.0"},"reference-count":52,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA038876"],"award-info":[{"award-number":["DA038876"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA038876"],"award-info":[{"award-number":["DA038876"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0184876","type":"journal-article","created":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T18:21:59Z","timestamp":1512152519000},"page":"e0184876","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":64,"title":["Safety and efficacy of an oxycodone vaccine: Addressing some of the unique considerations posed by opioid abuse"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9715-6962","authenticated-orcid":true,"given":"M. D.","family":"Raleigh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. J.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Laudenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Baruffaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. I.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. D.","family":"Comer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. A.","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. L.","family":"Langston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. P.","family":"Runyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Winston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Pravetoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. R.","family":"Pentel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,12,1]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/B978-0-12-420118-7.00014-7","article-title":"New directions in nicotine vaccine design and use","volume":"69","author":"PR Pentel","year":"2014","journal-title":"Adv Pharmacol"},{"issue":"9","key":"ref2","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1517\/14712598.2014.920319","article-title":"The future potential for cocaine vaccines","volume":"14","author":"FM Orson","year":"2014","journal-title":"Expert Opin Biol Ther"},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/bcp.12115","article-title":"Vaccines against stimulants: cocaine and MA","volume":"77","author":"T Kosten","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"ref4","first-page":"37","article-title":"Biologics to Treat Substance Use Disorders: Vaccines, monoclonal antibodies, and enzymes","author":"P Pentel","year":"2015"},{"issue":"10","key":"ref5","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.tips.2015.07.002","article-title":"Biologic Approaches to Treat Substance-Use Disorders","volume":"36","author":"P Skolnick","year":"2015","journal-title":"Trends Pharmacol Sci"},{"key":"ref6","first-page":"1","article-title":"Biologics to treat substance use disorders: Current status and new directions","author":"M Pravetoni","year":"2016","journal-title":"Hum Vaccin Immunother"},{"issue":"50\u201351","key":"ref7","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.15585\/mmwr.mm6450a3","article-title":"Increases in Drug and Opioid Overdose Deaths\u2014United States, 2000\u20132014","volume":"64","author":"RA Rudd","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref8","article-title":"The Role of Science in Addressing the Opioid Crisis","author":"ND Volkow","year":"2017","journal-title":"N Engl J Med"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40621-015-0041-8","article-title":"Effectiveness of bystander naloxone administration and overdose education programs: a meta-analysis","volume":"2","author":"RE Giglio","year":"2015","journal-title":"Inj Epidemiol"},{"issue":"8","key":"ref10","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1517\/13543784.16.8.1285","article-title":"Sustained-release naltrexone: novel treatment for opioid dependence","volume":"16","author":"SD Comer","year":"2007","journal-title":"Expert Opin Investig Drugs"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s11481-006-9023-5","article-title":"Drugs of abuse, immune modulation, and AIDS","volume":"1","author":"GA Cabral","year":"2006","journal-title":"Journal of neuroimmune pharmacology: the official journal of the Society on NeuroImmune Pharmacology"},{"issue":"4","key":"ref12","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1046\/j.1360-0443.1999.9444894.x","article-title":"Methadone-maintained former heroin addicts, including those who are anti-HIV-1 seropositive, comply with and respond to hepatitis B vaccination","volume":"94","author":"L Borg","year":"1999","journal-title":"Addiction"},{"issue":"8","key":"ref13","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1046\/j.1360-0443.2002.00147.x","article-title":"Compliance with hepatitis B vaccination in 1175 heroin users and risk factors associated with lack of vaccine response","volume":"97","author":"G Quaglio","year":"2002","journal-title":"Addiction"},{"issue":"22","key":"ref14","doi-asserted-by":"crossref","first-page":"9036","DOI":"10.1073\/pnas.1219159110","article-title":"Dynamic vaccine blocks relapse to compulsive intake of heroin","volume":"110","author":"JE Schlosburg","year":"2013","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref15","article-title":"A conjugate vaccine attenuates morphine- and heroin-induced behavior in rats","author":"Q Li","year":"2014","journal-title":"The international journal of neuropsychopharmacology \/ official scientific journal of the Collegium Internationale Neuropsychopharmacologicum"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1124\/jpet.112.201194","article-title":"Selective effects of a morphine conjugate vaccine on heroin and metabolite distribution and heroin-induced behaviors in rats","volume":"344","author":"MD Raleigh","year":"2013","journal-title":"The Journal of pharmacology and experimental therapeutics"},{"issue":"7","key":"ref17","doi-asserted-by":"crossref","first-page":"e101807","DOI":"10.1371\/journal.pone.0101807","article-title":"Effects of an oxycodone conjugate vaccine on oxycodone self-administration and oxycodone-induced brain gene expression in rats","volume":"9","author":"M Pravetoni","year":"2014","journal-title":"PloS one"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1124\/jpet.111.189506","article-title":"An oxycodone conjugate vaccine elicits drug-specific antibodies that reduce oxycodone distribution to brain and hot-plate analgesia","volume":"341","author":"M Pravetoni","year":"2012","journal-title":"The Journal of pharmacology and experimental therapeutics"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1021\/jm3013745","article-title":"Reduced antinociception of opioids in rats and mice by vaccination with immunogens containing oxycodone and hydrocodone haptens","volume":"56","author":"M Pravetoni","year":"2013","journal-title":"Journal of medicinal chemistry"},{"issue":"11","key":"ref20","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S1567-5769(01)00128-X","article-title":"Administration of mu-, kappa- or delta2-receptor agonists via osmotic minipumps suppresses murine splenic antibody responses","volume":"1","author":"RT Rahim","year":"2001","journal-title":"International immunopharmacology"},{"issue":"18","key":"ref21","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/0024-3205(79)90442-9","article-title":"Inhibition of drug metabolism by chronically administered naltrexone","volume":"25","author":"TM Lehman","year":"1979","journal-title":"Life Sci"},{"issue":"6","key":"ref22","first-page":"530","article-title":"Naltrexone microspheres: in vitro release and effect on morphine analgesia in mice","volume":"22","author":"GA He","year":"2001","journal-title":"Acta Pharmacol Sin"},{"issue":"5","key":"ref23","doi-asserted-by":"crossref","first-page":"e96547","DOI":"10.1371\/journal.pone.0096547","article-title":"Effect of currently approved carriers and adjuvants on the pre-clinical efficacy of a conjugate vaccine against oxycodone in mice and rats","volume":"9","author":"M Pravetoni","year":"2014","journal-title":"PloS one"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3109\/1547691X.2013.822948","article-title":"T-cell-dependent antibody responses in the rat: forms and sources of keyhole limpet hemocyanin matter","volume":"11","author":"H Lebrec","year":"2014","journal-title":"J Immunotoxicol"},{"key":"ref25","first-page":"514","article-title":"Poisoning and Drug Overdose","author":"J Wong","year":"2012"},{"issue":"Suppl 4","key":"ref26","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.1086\/508180","article-title":"Opioid dependence: rationale for and efficacy of existing and new treatments","volume":"43","author":"DA Fiellin","year":"2006","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1037\/0893-164X.17.3.203","article-title":"Acceptability and availability of harm-reduction interventions for drug abuse in American substance abuse treatment agencies","volume":"17","author":"H Rosenberg","year":"2003","journal-title":"Psychol Addict Behav"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1081\/ADA-120029870","article-title":"Barriers to enrollment in drug abuse treatment and suggestions for reducing them: opinions of drug injecting street outreach clients and other system stakeholders","volume":"30","author":"PW Appel","year":"2004","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"8","key":"ref29","doi-asserted-by":"crossref","first-page":"688","DOI":"10.7326\/0003-4819-137-8-200210150-00014","article-title":"New federal initiatives to enhance the medical treatment of opioid dependence","volume":"137","author":"DA Fiellin","year":"2002","journal-title":"Ann Intern Med"},{"key":"ref30","unstructured":"SAMHSA. National Survey on Drug Use and Health 2006. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.oas.samhsa.gov\/NSDUH\" xlink:type=\"simple\">http:\/\/www.oas.samhsa.gov\/NSDUH<\/ext-link>."},{"key":"ref31","first-page":"125","article-title":"New Medications for Addiction","author":"GE Woody","year":"2004"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3923\/jpt.2009.30.35","article-title":"Immunotherapy of 347 volunteer outpatient morphine addicts by human therapeutic morphine vaccine in Kermanshah province of Iran","volume":"4","author":"A Akbarzadeh","year":"2009","journal-title":"J Pharm Toxicol"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3923\/ajb.2007.58.65","article-title":"Study of human therapeutic morphine vaccine: Safety and immunogenicity","volume":"2","author":"A Akbarzadeh","year":"2007","journal-title":"Asian J Biochem"},{"issue":"3","key":"ref34","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1586\/erv.13.13","article-title":"Therapeutic vaccines against tobacco addiction","volume":"12","author":"RE Fahim","year":"2013","journal-title":"Expert review of vaccines"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.drugalcdep.2014.04.003","article-title":"Vaccine for cocaine dependence: a randomized double-blind placebo-controlled efficacy trial","volume":"140","author":"TR Kosten","year":"2014","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"ref36","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/clpt.2010.317","article-title":"Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic","volume":"89","author":"DK Hatsukami","year":"2011","journal-title":"Clinical pharmacology and therapeutics"},{"issue":"4","key":"ref37","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0031-6997(24)01514-X","article-title":"Animal models of nociception","volume":"53","author":"D Le Bars","year":"2001","journal-title":"Pharmacol Rev"},{"issue":"3","key":"ref38","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1521-0391.2011.00120.x","article-title":"Oxycodone abuse in New York City: characteristics of intravenous and intranasal users","volume":"20","author":"JD Jones","year":"2011","journal-title":"Am J Addict"},{"issue":"3","key":"ref39","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/FBP.0b013e3283536d6f","article-title":"Effects of repeated oxycodone administration on its analgesic and subjective effects in normal, healthy volunteers","volume":"23","author":"ZD Cooper","year":"2012","journal-title":"Behav Pharmacol"},{"issue":"1","key":"ref40","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1021\/acschembio.6b00977","article-title":"An Advance in Prescription Opioid Vaccines: Overdose Mortality Reduction and Extraordinary Alteration of Drug Half-Life","volume":"12","author":"A Kimishima","year":"2017","journal-title":"ACS Chem Biol"},{"issue":"11","key":"ref41","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1002\/anie.201511654","article-title":"Combatting Synthetic Designer Opioids: A Conjugate Vaccine Ablates Lethal Doses of Fentanyl Class Drugs","volume":"55","author":"PT Bremer","year":"2016","journal-title":"Angew Chem Int Ed Engl"},{"issue":"6","key":"ref42","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.intimp.2006.01.008","article-title":"Safety and efficiency of an anti-(+)-methamphetamine monoclonal antibody in the protection against cardiovascular and central nervous system effects of (+)-methamphetamine in rats","volume":"6","author":"WB Gentry","year":"2006","journal-title":"International immunopharmacology"},{"issue":"1\u20132","key":"ref43","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.drugalcdep.2012.09.007","article-title":"A vaccine against methamphetamine attenuates its behavioral effects in mice","volume":"129","author":"XY Shen","year":"2013","journal-title":"Drug and alcohol dependence"},{"issue":"2","key":"ref44","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1037\/1064-1297.9.2.228","article-title":"Inhibition of nicotine-induced seizures in rats by combining vaccination against nicotine with chronic nicotine infusion","volume":"9","author":"Y Tuncok","year":"2001","journal-title":"Exp Clin Psychopharmacol"},{"issue":"1","key":"ref45","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0091-3057(99)00206-3","article-title":"A nicotine conjugate vaccine reduces nicotine distribution to brain and attenuates its behavioral and cardiovascular effects in rats","volume":"65","author":"PR Pentel","year":"2000","journal-title":"Pharmacology, biochemistry, and behavior"},{"issue":"4","key":"ref46","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1021\/mp200588v","article-title":"An antidote for acute cocaine toxicity","volume":"9","author":"JB Treweek","year":"2012","journal-title":"Mol Pharm"},{"issue":"9","key":"ref47","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1111\/add.12208","article-title":"Injectable extended-release naltrexone (XR-NTX) for opioid dependence: long-term safety and effectiveness","volume":"108","author":"E Krupitsky","year":"2013","journal-title":"Addiction"},{"issue":"11","key":"ref48","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.vaccine.2016.01.051","article-title":"Active opioid use does not attenuate the humoral responses to inactivated influenza vaccine","volume":"34","author":"E Moroz","year":"2016","journal-title":"Vaccine"},{"issue":"9729","key":"ref49","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/S0140-6736(10)60349-2","article-title":"Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): a randomised trial","volume":"375","author":"J Strang","year":"2010","journal-title":"Lancet"},{"issue":"1","key":"ref50","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jss.2005.04.028","article-title":"Opiate analgesics contribute to the development of post-injury immunosuppression","volume":"129","author":"M Alexander","year":"2005","journal-title":"J Surg Res"},{"issue":"23","key":"ref51","first-page":"631","article-title":"Opioid Overdose Prevention Programs Providing Naloxone to Laypersons\u2014United States, 2014","volume":"64","author":"E Wheeler","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"31","key":"ref52","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1016\/j.vaccine.2012.04.101","article-title":"Co-administration of morphine and oxycodone vaccines reduces the distribution of 6-monoacetylmorphine and oxycodone to brain in rats","volume":"30","author":"M Pravetoni","year":"2012","journal-title":"Vaccine"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0184876","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T23:15:53Z","timestamp":1751066153000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0184876"}},"subtitle":[],"editor":[{"given":"Michael","family":"Taffe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,12,1]]},"references-count":52,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,12,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0184876","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,1]]}}}